Market Movers (8-K)
See all →OID
Global Innovative Platforms Inc. provides a shareholder update detailing progress in fundraising, scientific development, corporate governance, and strategic partnerships, alongside regulatory updates and team expansion.
Capital raise
OID
Global Innovative Platforms Inc. has appointed four new directors to its board, increasing the total board size from one to four members.
OID
Global Innovative Platforms Inc. announced it has posted an updated investor presentation on its corporate website.
OID
Global Innovative Platforms Inc. announced preliminary findings from its VOCAM Plus technology, showing early detection capabilities for heartworm infection in dogs, a significant advancement over current diagnostic methods.
Better than expected
OID
Global Innovative Platforms Inc. announced a new agreement for its VOCAM Plus diagnostic technology and a change in its independent registered public accounting firm.
OID
Global Innovative Platforms Inc. announced it has posted an updated investor presentation on its website for stakeholder review.
Quarterly Earnings (10-Q)
See all →OID
Global Innovative Platforms Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting initial revenue generation from its VetBreath Dx technology while continuing to incur operating losses.
Capital raise
Worse than expected
OID
Global Innovative Platforms reports its first revenue of $136,500 for the six months ended March 31, 2026, while continuing to navigate going concern uncertainties.
Capital raise
OID
Global Innovative Platforms, Inc. reported a significant net loss for Q3 2025 and the nine months ended June 30, 2025, while advancing its pet and agriculture gas outflow diagnostic technology and seeking additional capital.
Worse than expected
Capital raise
OID
Global Innovative Platforms reports a net loss of $271,817 for the six months ended March 31, 2025, as it continues to develop its breath analysis technology for animal health.
Worse than expected
Capital raise
OID
Global Innovative Platforms reports a net loss for the quarter ended December 31, 2024, and acknowledges substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OID
Global Innovative Platforms, Inc. reports ongoing losses and dependence on external funding, raising concerns about its ability to continue as a going concern.
Worse than expected
Capital raise
Annual Reports (10-K)
OID
Global Innovative Platforms Inc. reports significant R&D progress in breath analysis for animal disease detection, despite ongoing losses and a going concern warning.
Worse than expected
Capital raise
Delay expected
OID
Global Innovative Platforms Inc. has filed its annual 10-K report, highlighting its focus on developing breath analysis technology for animal health, particularly for early detection of heartworm in dogs.
Worse than expected
Delay expected
Capital raise
OID
Global Innovative Platforms Inc. has filed its annual 10-K report, detailing its development of a breath test for heartworm detection in dogs and its financial status.
Worse than expected
Delay expected
Capital raise
Insider Trading (Form 4)
See all →OID
Elyssa Jacob Campbell, a Director of Global Innovative Platforms Inc., received 20,000 shares of common stock on June 30, 2026.
OID
Andrew Nicholas Brown, CEO and CFO, a Director and 10% owner of Global Innovative Platforms Inc., received 250,000 shares of common stock on June 30, 2026.
OID
Andrew Brown, CEO and CFO of Global Innovative Platforms Inc., reported the acquisition of 500,000 shares of common stock through a Rule 10b5-1(c) plan.
OID
Director James Carl Jones of Global Innovative Platforms Inc. (GIPL) reported a sale of company stock on October 23, 2023.
OID
David A. Brown, a Director and 10% owner of Global Innovative Platforms Inc. (GIPL), reported the acquisition of 3,682,800 common shares on October 23, 2023.
OID
Global Innovative Platforms Inc.'s CEO and CFO, Andrew Nicholas Brown, reported a series of common stock acquisitions, increasing his direct beneficial ownership to 10,310,554 shares.
Better than expected
Schedule 13G - Passive Investments
OID
James C. Jones has reported beneficial ownership of 92,812 shares, representing 14.99% of the common stock of Global Innovative Platforms Inc., as of March 31, 2021.